Recordati SpAMEX:RECN 71 OCF Yield % is 5.18 as of Jun. 25, 2026, which is 11% above its 10-year median of 4.65. GuruFocus rates MEX:RECN with a GF Score™ of 71/100 and a GF Value™ of MXN1,150.23 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Recordati SpA ranks better than 59.5% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Recordati SpA OCF Yield % Related Terms
Recordati SpA OCF Yield % Historical Data
* Premium members only.
The historical data trend for Recordati SpA's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:RECN vs LLY, JNJ, ABBV: OCF Yield % Comparison
For the Drug Manufacturers - General subindustry, Recordati SpA's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Recordati SpA OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Recordati SpA's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Recordati SpA (MEX:RECN) has a OCF Yield % of 5.18 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Recordati SpA and its competitors. This is 11% above median its historical median of 4.65. Over the past decade, Recordati SpA's OCF Yield % has ranged from 2.87 to 6.62. According to the industry distribution chart, Recordati SpA ranks #407 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 40.5%.
Is Recordati SpA's OCF Yield % too high?
Recordati SpA's current OCF Yield % of 5.18 is 11% above median its 10-year median of 4.65. Over the past 10 years, this metric has ranged from a low of 2.87 to a high of 6.62. The Drug Manufacturers industry median OCF Yield % is 3.54. Recordati SpA's value of 5.18 is 46.3% above this industry median. Based on the distribution chart, Recordati SpA ranks #407 out of 1005 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Recordati SpA has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Recordati SpA's OCF Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Recordati SpA ranks #407 out of 1005 companies for OCF Yield %. This puts Recordati SpA in the upper half of its industry. The industry median OCF Yield % is 3.54. Recordati SpA's value of 5.18 is 46.3% above this benchmark. Historically, Recordati SpA's own OCF Yield % has ranged from 2.87 to 6.62 over the past decade. While the company's 10-year median is 4.65 vs. the industry median of 3.54, Recordati SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.54, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Recordati SpA's current OCF Yield % of 5.18 is 46.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Recordati SpA and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Recordati SpA's current OCF Yield % is 5.18, which is 11% above median its own 10-year median of 4.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Recordati SpA stock overvalued right now?
Based on GuruFocus' analysis, Recordati SpA (MEX:RECN) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,150.23, compared to a current price of MXN1,019.79 — trading 11.3% below its estimated fair value. The current OCF Yield % is 5.18, which is 11% above median its 10-year median of 4.65 and 46.3% above the Drug Manufacturers industry median of 3.54. Recordati SpA's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Recordati SpA (MEX:RECN), the current OCF Yield % is 5.18 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Recordati SpA (MEX:RECN) Overvalued in 2026?
Based on GuruFocus' analysis, Recordati SpA stock appears to be undervalued.
The current stock price of MXN1,019.79 is trading 11.3% below its estimated GF Value™ of MXN1,150.23.
GuruFocus considers Recordati SpA to be Modestly Undervalued.
Key valuation signals for MEX:RECN:
OCF Yield %: 5.18 (11% above median its 10-year median of 4.65)
GF Value™: MXN1,150.23 vs. price of MXN1,019.79 (11.3% below fair value)
Industry Position: 46.3% above the Drug Manufacturers median (#407 of 1005)
No single metric tells the full story. See the MEX:RECN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Recordati SpA is engaged in the development, production, and marketing of pharmaceutical products or of pharmaceutical chemicals. The Company operates in a broad and diverse context, which includes general medicine, specialist medicine, self-medication, and rare diseases. In addition, it is also active in the field of urology, with treatments for benign prostatic hyperplasia and male functional disorders, and in psychiatry. The Company's only operating segment is the Specialty & Primary Care segment. Its geographic areas are Europe, Australasia, America, and Africa.
71GF Score
Get the complete analysis for MEX:RECN
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:RECN has been successfully added to your 
